Dr. Carlos Macaya Miguel, head of the Cardiology Service of the San Carlos University Clinical Hospital and professor at the Complutense University of Madrid (UCM), comments on three cardiovascular news in the “Noticiero del Corazón”: If your bad cholesterol is loose, it bites you insurance; with more fury if you are a cardiac patient. Multivitamins can satisfy your stomach, but not your cardiovascular system. The Spanish Journal of Cardiology is proud for the publication of international research.
Cardiac patients should hypercontrol their cholesterol
According to experts, when a patient has suffered an acute myocardial infarction is 50% more likely to suffer a second cardiovascular event if the safety limits set for the index of bad cholesterol in blood are exceeded; hypercholesterolemia situation that causes up to 25% of deaths from cardiovascular disease in countries such as Spain.
High rates of LDL cholesterol (popularly known as “bad cholesterol”) are considered by specialists to be one of the most important causes of cardiovascular disease.
However, at present less than half of the patients who have already suffered a first cardiovascular event and who receive lipid-lowering treatment (reducing blood lipid levels) have adequate levels of LDL, as shown by the results of the study. multi-center study EUROASPIRE V.
In these patients the goal of LDL cholesterol should be less than 70mg / dl
Pursuing this figure is key to longevity and quality of life, since for each reduction of 40 mg / dl in LDL cholesterol levels the relative risk of cardiovascular events falls between 20% and 25% .
One of the main messages that emphasizes Dr. Carlos Macaya Miguel , also chairman of the FEC, is that ” the 80% of cardiovascular diseases are preventable , prevention based on maintaining a healthy lifestyle and controlling main risk factors. A figure that contrasts with the fact that diseases of the circulatory system continue to be the leading cause of death not only in Spain, but worldwide . “
The Spanish Heart Foundation (FEC) reports that hypercholesterolemia is responsible for approximately a quarter of mortality due to cardiovascular causes . Thus, high cholesterol causes in our country 24.6% of deaths in the case of men and 22.5% in women.
In addition, the Study of Nutrition and Cardiovascular Risk in Spain (ENRICA) revealed that more than half of the population has hypercholesterolemia (total cholesterol ≥ 200mg / dl), but only one in two is diagnosed .
Multivitamins do not promote cardiovascular health
Taking multivitamin and mineral supplements does not prevent heart attacks, strokes or cardiovascular death, according to a study published in the American Heart Association journal.
The research team broadly evaluated 18 previously published individual studies, including randomized controlled trials and prospective cohort analyzes, which totaled a total of more than two million participants and averaged 12 years of follow-up.
When reviewing all these reports, they found no association between taking multivitamin and mineral supplements and a lower risk of death from cardiovascular disease.
The researcher hopes that these results “help reduce the hype” around these supplements and that encourages people to use proven methods to reduce the risk of cardiovascular disease, such as eating more fruits and vegetables, exercise and avoiding tobacco.
Approximately 30% of Americans consume multivitamin and mineral supplements, and the global nutritional supplement industry is expected to reach 278 billion dollars (240 billion euros) by 2024.
The controversy over the effectiveness of multivitamin and mineral supplements in preventing cardiovascular disease has been at the center of scientific debate for years, despite numerous research studies suggesting that they do not help.
Among their recommendations, they assured that it is important to include a heart-healthy diet, exercise, stop smoking, control blood pressure and unhealthy cholesterol levels, and when necessary, medical treatment.
Revista Española de Cardiología, in the world “top”
REC , the Spanish Journal of Cardiology, has achieved an impact factor of 5,166 in the latest edition of the Journal Citation Reports (JCR). The figure represents an increase compared to the figure of 2017 ( 4,485 ) and represents the highest impact factor in the history of the scientific publication of the Spanish Society of Cardiology (SEC).
The impact factor is a measure that is related to the visibility of the journals and is greater in that the articles published by a journal in two consecutive years are cited in the third year in other indexed publications.
With this increase in its impact factor, REC is once again in the first quartile of cardiovascular journals:
The editorial team is “very satisfied” and, at the same time, with the feeling of facing a great “responsibility” to maintain the level achieved, REC’s chief editor, Dr. Ignacio Ferreira, recently declared.
To try to maintain the good level obtained, the REC team will continue working as before: selecting the best articles from the scientific point of view, originality and interest. All that, without forgetting details such as the quality of the format and the translations.
From REC they assure that, in addition, they intend to launch a new header “REC: CardioClinics” with which to give partial response to the great demand for publication in the cardiology area.